3[2]Harris JR,Lippman ME,Morrow M,et al. Disease of the breast[M].Lippincott Williams ( second edition), 1999.799-807.
4[3]Takano S,Gately S,Neville ME,et al .Suramin,an anticancer and angiosuppressive agent,inhibits endothelial cell binding of basic fibroblast growth factor, proliferation, and induction of urokinase-type plasminogen activator [J]. Cancer Res, 1994,54(10) :2654-2660.
5[4]Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J]. Nature, 1997,390 ( 6658 ): 404-407.
6[5]Staddon A,Henry D,Bonnem E.A randomized dose finding study of recombinant human platelet fator4 in cutaneous AIDS-related Kaposi' s sarcoma [J]. Proc Am Soc Clin Oncol, 1994,13: 50.
7[6]Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth[J]. Nature,190,348(6301 ): 555-557.
8[7]Takamiya Y,Brem H,Ojeifo J,et al. AGM-1470 inhibits the growth of the human glioblastoma cells in vitro and in vivo[J ]. Neurosurgery,1994,34(5) :869-875.
9[8]Offodile R,Walton T, Lee M, et al. Regression of metastatic breast cancer in a patient treated with the anti-angiogenic drug TNP-470[J].Tumori, 1999,85(1):51-53.
10[9]Steward WP. Marimastat (BB2516): current status of development.Cancer Chemother Pharmacol, 1999,43(Suppl) :56-60.
